MARKER LUKE JOSEPH 4

What Happened

• Marker Luke Joseph, a director of Maravai LifeSciences Holdings, Inc. (MRVI), was granted 46,293 restricted stock units (RSUs) on May 26, 2026. The award was reported as 46,293 shares at $0.00, total reported value $0 (non-cash equity award).
• This was an equity grant (award), not an open-market purchase or sale.

Key Details

• Transaction date: May 26, 2026; Form 4 filed May 28, 2026 (appears timely — filed within two business days).
• Grant details: 46,293 RSUs granted @ $0.00 (reported value $0).
• Vesting: RSUs vest in full upon the earlier of one year from grant or the date of the 2027 Maravai annual meeting of stockholders (per filing footnote).
• Shares owned after transaction: not specified in the provided filing details.
• Reporting note: The reporting person holds these securities for the benefit of a GTCR‑affiliated entity and disclaims pecuniary interest; this report may not indicate beneficial ownership under Section 16.

Context

• RSU grants are a common form of executive/director compensation and do not involve cash changing hands at grant; they typically convert to actual shares upon vesting.
• Because the reporting person indicates the RSUs are held for a GTCR‑affiliated entity, this appears to reflect an institutional allocation rather than a personal open‑market investment decision.